CC
ASPN icon

Cambrian Capital’s Aspen Aerogels ASPN Stock Holding History

Cambrian Capital’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-79,600
Closed -$474K – 45
2016
Q3 		$474K Hold
79,600
– – 0.27% 51
2016
Q2 		$396K Buy
+79,600
New +$349K 0.24% 46

Other funds holding ASPN

GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $1.04B AUM 36.93% 1-Year Est. Return
RO
Reservoir Operations New York $13.2M AUM 10.1% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Cambrian Capital's ASPN Position: Q4 2016 in Review

Cambrian Capital sold out of Aspen Aerogels (ASPN) in Q4 2016, closing a stake of 79,600 shares — an estimated $474K sold.

Cambrian Capital first reported a position in ASPN in Q2 2016 and held it in 2 quarters. The position peaked at $474K in Q3 2016. 54 funds tracked by Wall St. Rank hold ASPN as of Q4 2016.

  • Cambrian Capital reported no remaining Aspen Aerogels position as of Q4 2016 after selling out during the quarter.
  • Cambrian Capital sold 79,600 Aspen Aerogels shares in Q4 2016, an estimated $474K.
  • Cambrian Capital first reported a position in Aspen Aerogels in Q2 2016 and held it in 2 quarters.
  • Cambrian Capital's Aspen Aerogels position peaked at $474K in Q3 2016.
  • 54 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2016.

Based on Cambrian Capital's 13F filing for Q4 2016, filed 14 Feb 2017.